−0.48 TRY
73.43 M TRY
2.09 B TRY
24.45 M
About Meditera Tibbi Malzeme Sanayi Ve Ticaret A.S.
Sector
Industry
Website
Headquarters
Karabaglar
Founded
1996
ISIN
TREMDTR00028
FIGI
BBG011J5DGS4
Meditera Tibbi Malzeme Sanayi ve Ticaret AS engages in manufacturing medical devices. The company was founded on February 14, 1996 and is headquartered in Karabaglar, Turkey.
Related stocks
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of MEDTR is 28.60 TRY — it has increased by 1.17% in the past 24 hours. Watch Meditera Tibbi Malzeme Sanayi Ve Ticaret A.S. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on BIST exchange Meditera Tibbi Malzeme Sanayi Ve Ticaret A.S. stocks are traded under the ticker MEDTR.
MEDTR stock has fallen by −5.71% compared to the previous week, the month change is a −1.47% fall, over the last year Meditera Tibbi Malzeme Sanayi Ve Ticaret A.S. has showed a −35.00% decrease.
We've gathered analysts' opinions on Meditera Tibbi Malzeme Sanayi Ve Ticaret A.S. future price: according to them, MEDTR price has a max estimate of 44.00 TRY and a min estimate of 44.00 TRY. Watch MEDTR chart and read a more detailed Meditera Tibbi Malzeme Sanayi Ve Ticaret A.S. stock forecast: see what analysts think of Meditera Tibbi Malzeme Sanayi Ve Ticaret A.S. and suggest that you do with its stocks.
MEDTR reached its all-time high on Jan 9, 2025 with the price of 55.00 TRY, and its all-time low was 8.72 TRY and was reached on Jul 14, 2021. View more price dynamics on MEDTR chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
MEDTR stock is 3.22% volatile and has beta coefficient of 0.67. Track Meditera Tibbi Malzeme Sanayi Ve Ticaret A.S. stock price on the chart and check out the list of the most volatile stocks — is Meditera Tibbi Malzeme Sanayi Ve Ticaret A.S. there?
Yes, you can track Meditera Tibbi Malzeme Sanayi Ve Ticaret A.S. financials in yearly and quarterly reports right on TradingView.
MEDTR net income for the last quarter is −19.56 M TRY, while the quarter before that showed −69.99 M TRY of net income which accounts for 72.06% change. Track more Meditera Tibbi Malzeme Sanayi Ve Ticaret A.S. financial stats to get the full picture.
Meditera Tibbi Malzeme Sanayi Ve Ticaret A.S. dividend yield was 0.48% in 2024, and payout ratio reached 40.85%. The year before the numbers were 1.06% and 135.29% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Oct 17, 2025, the company has 786 employees. See our rating of the largest employees — is Meditera Tibbi Malzeme Sanayi Ve Ticaret A.S. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Meditera Tibbi Malzeme Sanayi Ve Ticaret A.S. EBITDA is 270.61 M TRY, and current EBITDA margin is 14.77%. See more stats in Meditera Tibbi Malzeme Sanayi Ve Ticaret A.S. financial statements.
Like other stocks, MEDTR shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Meditera Tibbi Malzeme Sanayi Ve Ticaret A.S. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Meditera Tibbi Malzeme Sanayi Ve Ticaret A.S. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Meditera Tibbi Malzeme Sanayi Ve Ticaret A.S. stock shows the strong sell signal. See more of Meditera Tibbi Malzeme Sanayi Ve Ticaret A.S. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.